Clinical trial
A Randomized Controlled Trial of Port Site Subcutaneous Injection of Bupivacaine to Determine the Effectiveness of Postoperative Pain Relief After Laparoscopic Cholecystectomy
NCT05264805 is registered in ClinicalTrials.gov with Hamdard University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Trial of Port Site Subcutaneous Injection of Bupivacaine to Determine the Effectiveness of Postoperative Pain Relief After Laparoscopic Cholecystectomy
- Lead sponsor
- Hamdard University
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- March 31, 2022
- Completion date
- September 30, 2022
- Enrollment
- 166 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
pain, postoperative